353 related articles for article (PubMed ID: 19748810)
1. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II.
Wang RY; Cambray-Forker EJ; Ohanian K; Karlin DS; Covault KK; Schwartz PH; Abdenur JE
Mol Genet Metab; 2009 Dec; 98(4):406-11. PubMed ID: 19748810
[TBL] [Abstract][Full Text] [Related]
2. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
[TBL] [Abstract][Full Text] [Related]
3. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.
Tanaka A; Okuyama T; Suzuki Y; Sakai N; Takakura H; Sawada T; Tanaka T; Otomo T; Ohashi T; Ishige-Wada M; Yabe H; Ohura T; Suzuki N; Kato K; Adachi S; Kobayashi R; Mugishima H; Kato S
Mol Genet Metab; 2012 Nov; 107(3):513-20. PubMed ID: 23022072
[TBL] [Abstract][Full Text] [Related]
5. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies.
Nan H; Park C; Maeng S
Biomed Res Int; 2020; 2020():2408402. PubMed ID: 33344633
[No Abstract] [Full Text] [Related]
6. Mucopolysaccharidoses type I and II: new neuroimaging findings in the cerebellum.
Alqahtani E; Huisman TA; Boltshauser E; Scheer I; Güngör T; Tekes A; Maegawa GH; Poretti A
Eur J Paediatr Neurol; 2014 Mar; 18(2):211-7. PubMed ID: 24423630
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.
Higuchi T; Shimizu H; Fukuda T; Kawagoe S; Matsumoto J; Shimada Y; Kobayashi H; Ida H; Ohashi T; Morimoto H; Hirato T; Nishino K; Eto Y
Mol Genet Metab; 2012 Sep; 107(1-2):122-8. PubMed ID: 22704483
[TBL] [Abstract][Full Text] [Related]
8. Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: comparison in two siblings.
Tajima G; Sakura N; Kosuga M; Okuyama T; Kobayashi M
Mol Genet Metab; 2013 Mar; 108(3):172-7. PubMed ID: 23375472
[TBL] [Abstract][Full Text] [Related]
9. Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses.
Jones SA; Marsden D; Koutsoukos T; Sniadecki J; Tylee K; Phillippo S; Kakkis E
Mol Genet Metab; 2020 Aug; 130(4):255-261. PubMed ID: 32563631
[TBL] [Abstract][Full Text] [Related]
10. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses.
Frawley G; Fuenzalida D; Donath S; Yaplito-Lee J; Peters H
Paediatr Anaesth; 2012 Aug; 22(8):737-44. PubMed ID: 22381044
[TBL] [Abstract][Full Text] [Related]
11. Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness.
Wang RY; Braunlin EA; Rudser KD; Dengel DR; Metzig AM; Covault KK; Polgreen LE; Shapiro E; Steinberger J; Kelly AS
Mol Genet Metab; 2014 Feb; 111(2):128-32. PubMed ID: 24268528
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic biomonitoring in mucopolyssacharosis I, II and IV patients treated with enzyme replacement therapy.
Guilheiro JM; Chaves MD; Martins AM; Ribeiro DA; D'Almeida V
Toxicol Mech Methods; 2014 Dec; 24(8):603-7. PubMed ID: 25141890
[TBL] [Abstract][Full Text] [Related]
13. Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.
Yund B; Rudser K; Ahmed A; Kovac V; Nestrasil I; Raiman J; Mamak E; Harmatz P; Steiner R; Lau H; Vekaria P; Wozniak JR; Lim KO; Delaney K; Whitley C; Shapiro EG
Mol Genet Metab; 2015 Feb; 114(2):170-7. PubMed ID: 25541100
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.
Kubaski F; Yabe H; Suzuki Y; Seto T; Hamazaki T; Mason RW; Xie L; Onsten TGH; Leistner-Segal S; Giugliani R; Dũng VC; Ngoc CTB; Yamaguchi S; Montaño AM; Orii KE; Fukao T; Shintaku H; Orii T; Tomatsu S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1795-1803. PubMed ID: 28673849
[TBL] [Abstract][Full Text] [Related]
15. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
16. Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.
Pal AR; Langereis EJ; Saif MA; Mercer J; Church HJ; Tylee KL; Wynn RF; Wijburg FA; Jones SA; Bruce IA; Bigger BW
Orphanet J Rare Dis; 2015 Apr; 10():42. PubMed ID: 25887468
[TBL] [Abstract][Full Text] [Related]
17. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation.
Matheus MG; Castillo M; Smith JK; Armao D; Towle D; Muenzer J
Neuroradiology; 2004 Aug; 46(8):666-72. PubMed ID: 15205860
[TBL] [Abstract][Full Text] [Related]
18. The natural history of neurocognition in MPS disorders: A review.
Shapiro EG; Eisengart JB
Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
[TBL] [Abstract][Full Text] [Related]
20. Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.
Tanjuakio J; Suzuki Y; Patel P; Yasuda E; Kubaski F; Tanaka A; Yabe H; Mason RW; Montaño AM; Orii KE; Orii KO; Fukao T; Orii T; Tomatsu S
Mol Genet Metab; 2015 Feb; 114(2):161-9. PubMed ID: 25468646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
